Stopping a medication is a prescribing decision and it has to be written with the same rigour as starting one. The territory at this stage is subtraction: choosing which agent goes first, deciding whether it can stop outright or requires a graded reduction, predicting what withdrawal or symptom return would look like and when, monitoring the removal, agreeing it with a patient who may have taken the drug for a decade, and recording the reasoning so the next prescriber does not simply restart it. Your section may print this as NR 568 or NR568; it is the same course. Chamberlain publishes no syllabi outside Canvas. The placement here is our teaching judgment from the course's catalog arc; your section's rubric decides what your week actually asks.
What NR-568 Week 6 asks for
Why do capable students write thin deprescribing sections? Because nothing in their training rewarded subtraction, and because a stop looks like an absence of work. On paper it is the opposite. A defensible removal contains more moving parts than a defensible addition: a justification, a sequence, a schedule, a prediction about what the patient will experience, a monitoring plan for a period when the drug is leaving the body, a restart condition, and a documented rationale that survives into the next visit. All of that is gradable, and most of it is missing from the average submission.
The clinic floor scene here is a return visit. A 74 year old woman comes back to a community health center four weeks after a review in which one agent was reduced. She feels worse. The clinically important question is whether what she is feeling is the condition returning, a withdrawal effect from the drug she reduced, or something unrelated that happened to coincide, and the three have different answers. A plan written in advance would have predicted what each of those would look like and when. A plan that only said reduce and review has left the clinician who sees her with nothing to reason from.
Deliverables at this depth are usually a written deprescribing plan built on a case list, sometimes a comparison of approaches for two agents, and often a posted response. Look for the row that asks about patient involvement, since agreement is not a courtesy in this territory: an unagreed reduction is simply a prescription the patient will not follow.
The boundary the course keeps stays in place. Support here is for the written and analytic layer of graduate work built to a scoring guide. Clinical hours, preceptor documentation and any decision to change a real patient's therapy are your own record and your own professional responsibility.
The NR-568 Week 6 method, step by step
Six moves for writing a removal that a colleague could carry out.
-
Locate the row about patient involvement or shared decisions
Deprescribing guides almost always contain one and students almost always underfill it. Written properly, with the actual conversation and the patient's stated concern addressed, it is among the most reliable points available at this stage.
-
Justify the specific agent you are removing first
Say why this one before the others: highest potential for harm, weakest remaining indication, most reversible, or most burdensome to the patient. Naming the criterion is what makes the sequence a decision rather than an order of appearance.
-
Decide between stopping and tapering, with a reason
Some agents can stop outright and some produce a withdrawal effect or a rebound if they do. State which applies here, and if a taper is needed, give the steps and the interval between them.
-
Predict what the patient will experience and when
Distinguish in advance between the underlying condition returning, a withdrawal effect and an unrelated event, and say what each would look like and in what time frame. This is the paragraph that makes the follow-up visit interpretable.
-
Write one change at a time and say why
Two simultaneous reductions make the outcome uninterpretable. State that you are removing one agent at a time, name the interval before the next change, and say what has to be stable before you proceed.
-
Give the plan a restart condition and a record
What would justify resuming the drug, at what dose, and what you would document so the reasoning survives. Without the record, the agent is usually restarted by default at the next transition of care.
A layout and word budget for a deprescribing plan
Our frame for a subtraction plan, sized for roughly 1,200 to 1,500 words. It is our own teaching outline rather than anything the university issues, and your section's scoring guide outranks it wherever they disagree.
| Section | What belongs in it | Word target |
|---|---|---|
| The candidate and the criterion | The agent chosen for removal first and the explicit basis on which it was selected ahead of the others. | 190 to 230 |
| Why its place is no longer earned | The indication that has lapsed, the harm that now outweighs benefit, or the burden the patient has described. | 210 to 250 |
| Stop or taper | The decision with its pharmacological reason, and where a taper applies, the steps and the interval between them. | 220 to 270 |
| What to expect and when | Condition return, withdrawal effect and coincidence distinguished in advance, each with its expected timing. | 220 to 260 |
| Monitoring and sequencing | What is watched, by whom, at what interval, and why only one change is being made at a time. | 180 to 220 |
| Agreement and record | The conversation in plain language, the restart condition, and what you would document about the reasoning. | 220 to 260 |
Evidence craft for deprescribing writing
Support the removal as carefully as you would support an addition. Deprescribing has its own literature, including work on which agents can be stopped safely and how withdrawal presents. A paper that cites thoroughly when adding and asserts when subtracting has an asymmetry that is easy to see.
Taper schedules are often expert consensus rather than trial output. Say so when it is true. Naming the strength of the evidence behind a schedule is more honest and better scoring than presenting a consensus regimen as though it had been tested against alternatives.
Withdrawal timing is a factual claim and needs a source. If you predict that an effect appears within a certain number of days, that comes from somewhere and it belongs with a citation, a population and a period rather than from general impression.
Absence of benefit is different from evidence of harm. Both can justify removal and they are different arguments with different evidence requirements. Say which one you are making, and if it is the first, be clear that the case rests on the indication having lapsed.
Trial evidence for stopping is thinner than for starting. Acknowledge that in a sentence where it applies, and explain what you are reasoning from instead. Graders in graduate pharmacology treat that acknowledgment as a strength rather than as a gap in preparation.
Five mistakes that cost points in this week's territory
- Several agents stopped at once. When two changes happen together, the outcome cannot be attributed to either, and the monitoring plan becomes uninterpretable before it starts.
- Taper asserted with no schedule. Reduce gradually is not a plan. Steps, intervals and the criterion for moving to the next step are what a colleague would need.
- No prediction of what the patient will feel. Without a stated expectation, neither the patient nor the next clinician can tell a withdrawal effect from a returning condition.
- Agreement treated as a formality. A reduction the patient has not accepted will not happen, and a paper that skips the conversation has skipped the step that determines the outcome.
- No restart condition. Stopping without saying what would justify resuming leaves the next clinician to decide from scratch, usually by restarting.
- Composing the post in Canvas. Entries cannot be edited once submitted, so build the taper in a document, check every step, then paste.
Before you submit
- The first agent for removal is named with the criterion that selected it
- The stop or taper decision carries a pharmacological reason
- Any taper is written as steps with intervals and a progression rule
- Condition return and withdrawal effect are distinguished in advance with timings
- Only one change is made at a time, and the paper says so explicitly
- A restart condition and a documentation plan both appear
Writing a deprescribing plan this week?
Send the case and the scoring guide out of Canvas. A premium original draft comes back in 24 to 48 hours with the taper written as steps and the expected experience predicted in advance, and revisions run until the grade lands.